| Timings | Topic | Speaker |
| 0830 - 0930 | Registration and refreshments | |
| 0930 | JBDS-IP: a year in review and looking ahead | Dr Omar Mustafa, Chair, JBDS-IP Consultant diabetologist, King’s College Hospital NHS Foundation Trust, London |
| Session 1 Chair: Dr Omar Mustafa | ||
| Inpatient diabetes: GIRFT | Professor Gerry Rayman, Consultant Diabetologist, East Suffolk and North Essex NHS Foundation Trust, Ipswich and GIRFT Diabetes Co-Lead NHSE |
|
| Inpatient diabetes care: safety, accreditation, quality, new national audit | Dr Daniel Flanagan, Consultant in diabetes and endocrinology, University Hospitals Plymouth NHS Trust, Plymouth Clinical Lead, Diabetes Care Accreditation programme and National Diabetes Audit (Inpatient Care) |
|
| Update on new JBDS-IP guidelines | ||
| The use of variable rate intravenous insulin infusion (VRIII) in medical inpatients | Dr Stella George, Consultant in diabetes and endocrinology, East and North Hertfordshire NHS Trust, Stevenage |
|
| Using technology to support diabetes care in hospital | Dr Pari Avari, Consultant Diabetologist, Imperial College Healthcare NHS Trust, London |
|
| Refreshments | ||
|
Session 2: A year in inpatient diabetes Updates on key clinical, research, and innovations developments in inpatient diabetes from speakers from the UK and internationally. |
||
| Practical approaches for inpatient continuous glucose monitoring, insulin pumps, and automated insulin delivery systems: International position statement | Dr Mikkel T. Olsen, Steno Diabetes Center Copenhagen, Herlev, Denmark |
|
| PREM in inpatient diabetes |
Dr Olga Kozlowska, Oxford Institute of Applied Health Research, Oxford Brookes University, Oxford Dr Rustam Rea, Consultant diabetologist, Oxford University Hospitals NHS Foundation Trust, Oxford |
|
| Health Services Safety Investigations Body (HSSIB) report: Insulin: supporting safe administration in inpatient settings | Mr Craig Hadley, Senior Safety Investigator, Health Services Safety Investigations Body (HSSIB) | |
| Optimising inpatient management of steroid induced hyperglycaemia: Insulin dosing strategies and diabetes technology | Dr Angela Chen, Consultant endocrinologist, Department of Endocrinology, Flinders Medical Centre, Bedford Park, Australia. | |
| Feasibility of using algorithm-guided basal–bolus therapy in corticosteroid-treated inpatients using routine clinical data | Ms Petra Martina Baumann, Medical University of Graz | |
|
Session 3: Workshops • All attendees rotate through all 3 workshops. |
||
| Lunch, posters and exhibition | ||
|
Workshop 1: Optimising inpatient diabetes care and safe discharge Facilitators: Dr Stella George, Consultant Diabetes and Endocrinology, East and North Hertfordshire Teaching NHS Trust, Stevenage |
||
|
Workshop 2: use of diabetes technology in hospital Facilitators: Dr Pari Avari |
||
| Refreshments | ||
|
Workshop 3: Perioperative care of people with diabetes undergoing surgery Facilitators: Dr Nicholas Levy, Consultant anaesthetist, West Suffolk NHS Foundation Trust Bury St Edmunds, Suffolk |
||
|
Closing plenary: • Key evidence gaps and unresolved challenges in inpatient diabetes management |
Professor Guillermo E. Umpierrez, Professor of Medicine Emory University School of Medicine, Atlanta, Georgia, USA |
|
| 1620 | Closing remarks and awards | |
